BROOMFIELD, Colo., Oct. 24, 2011 /PRNewswire/ -- Accera, Inc., a biotech company specializing in cognitive health, announced today the company has donated $50,000 to the Alzheimer's Foundation of America (AFA) for sponsorship of its "National Memory Screening Day" (NMSD) during National Alzheimer's Disease Awareness Month. These funds will be used to further the AFA's efforts to educate and support individuals with Alzheimer's disease (AD) and their families, especially about the importance of early detection of memory problems.
Eric J. Hall, founding president and CEO of AFA, said, "We're grateful that despite the difficult economy, Accera continues to demonstrate its generous commitment to individuals and their families facing Alzheimer's disease now or in the future. It's a public health crisis that requires corporate engagement."
NMSD, an annual initiative sponsored by AFA, provides free, confidential, memory screenings to individuals concerned about memory loss with the objective of early detection and intervention. Qualified healthcare professionals offer the face-to-face screenings and distribute educational materials about memory concerns and successful aging in communities across the nation on November 15.
Samuel Henderson, Ph.D., vice president of research and development for Accera, stated, "On behalf of the Accera team, we're happy to contribute to AFA's ongoing efforts of helping those affected by Alzheimer's and raise awareness about the options available to patients and their caregivers." He continued, "It's our hope that through continued awareness initiatives such as NMSD, we can better educate patients and their families about this devastating disease."
About Alzheimer's disease
AD significantly impacts millions of family members and other caregivers – mentally, physically and financially. The national Family Caregiver Alliance estimates that approximately 80 perc
|SOURCE Accera, Inc.|
Copyright©2010 PR Newswire.
All rights reserved